Delivery Order SPE2DP24D0005-SPE2DP24F6223
Award Date
7/18/24
Potential Completion Date
9/20/24
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,603,484.86 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services to Glaxosmithkline, LLC for the supply of influenza vaccine for the 2015-2016 season. The contract did not have a set-aside designation. Glaxosmithkline, a pharmaceutical company that provides vaccines and other products to federal agencies, was the prime contractor on this award. The contract was performed at Glaxosmithkline's facilities in Research Triangle Park, North...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
The Department of Veterans Affairs Veterans Health Administration awarded Glaxosmithkline, LLC, a $33,792.75 firm fixed price delivery order contract for flu vaccines. The contract has no set-aside designation and will be performed at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline is a pharmaceutical company that provides a range of products to federal government agencies, including vaccines, antiviral medications, and other pharmaceutical goods. This award is part of...
This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
Glaxosmithkline, LLC has been awarded a $58,770 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to provide FLUARIX influenza virus vaccines. Performance will occur at Glaxosmithkline's Durham, North Carolina facility through October 15, 2024. Glaxosmithkline holds several indefinite delivery contracts with federal agencies to supply seasonal influenza vaccines and other pharmaceutical products,...
The Department of Veterans Affairs Veterans Health Administration awarded a $281,138.00 firm fixed price delivery order to Glaxosmithkline, LLC for the emergency procurement of influenza vaccines. This award was not set aside and the performance will take place at Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline is a foreign-owned, for-profit pharmaceutical company that provides a range of vaccine and antiviral products to U.S. government agencies through...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VA/VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of flu vaccines for fiscal year 2019. The potential value of the order is $142,272.00. The order has no set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a range of pharmaceutical products and services to U.S. government...
This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...